Monthly Medicines Roundup for July

1st August 2026

Interested in the reading our Monthly Medicines Roundups for July?

Click the button below to find out more:

NHS England Approves Funding for Life-Changing Cystinosis Treatment

27th July 2026

NHS England has approved funding for Procysbi, a life-changing treatment for patients in England living with cystinosis. Following years of campaigning, this decision allows patients to switch from a demanding six-hour dosing schedule to a 12-hour regimen, significantly improving quality of life and routine.

Click the button below to find out more:

Community Conference 2026

Taking place: 14th-15th November

Get your free tickets to our annual community conference.

Click the button below to learn more and get your tickets:

Metabolic Support Community Survey

10th July 2026

Help shape how we support people living with Inherited Metabolic Disorders (IMDs).

Click the button below to respond to our community survey:

Monthly Medicines Roundup for June

1st July 2026

Interested in the reading our Monthly Medicines Roundups for June?

Click the button below to find out more:

Monthly Medicines Roundup for May

1st June 2026

Interested in the reading our Monthly Medicines Roundups for May?

Click the button below to find out more:

Beverley Ladies Day

27th May 2026

The 13th Annual Ladies Day at Beverley Rugby Club raised an incredible £2,051.25 for Metabolic Support. The event brought together members of the local community for a day of fundraising, food, entertainment and rugby, while also raising awareness of IMDs and the work of the charity.

Click the button below to find out more:

Aiza's Story: MoCD

15th May 2026

Aiza was diagnosed with Molybdenum Cofactor Deficiency (MoCD), an ultra-rare genetic condition, following a stay at Great Ormond Street Hospital after early concerning symptoms. Her story is being shared to raise awareness of MoCD and the realities faced by families living with ultra-rare conditions.

Click the button below to find out more:

Freya's story: HFI

15th May 2025

Freya lives with Hereditary Fructose Intolerance (HFI). Her story highlights how early symptoms were repeatedly misunderstood, leading to leading to severe illness, frequent hospital visits, and serious concern for her wellbeing. A genetic test later confirmed HFI, and a strict fructose-free diet transformed her health.

Click the button below to read her story:

Monthly Medicines Roundup for April

1st May 2026

Interested in the reading our Monthly Medicines Roundups for April?

Click the button below to find out more:

Introducing Metabolic Support Sri Lanka

8th April 2026

Explore our collaborative initiative in Sri Lanka to improve outcomes for people living with IMDs. This page includes a report, recordings and a gallery from the inauguration of Metabolic Support Sri Lanka. 🇱🇰

Click the button below to find out more:

Brews & Views: Bereavement

22nd April 2026

Our last “Brews and Views” session centred around Bereavement. Hear from Helen, who presented at the session with information and advice about bereavement.

Click the button below to find out more:

Monthly Medicines Roundup for March

1st April 2026

Interested in the reading our Monthly Medicines Roundups for March?

Click the button below to find out more:

ERDAP 2026 and Rare Conditions

1st April 2026

Interested in what the latest iteration of the England Rare Disease Action Plan means for people living with rare diseases?

Click the button below to read our article:

Monthly Medicines Roundup for February

1st March 2026

Interested in the reading our Monthly Medicines Roundups for February.

Click the button below to find out more:

Our Next Chapter: Metabolic Support

Rare Disease Day (28th February 2026)

Discover the vision behind our new name and how Metabolic Support will continue to expand services, connections and advocacy for people the 1.43 million people living with IMDs globally.

Click the button below to find out more:

Travel Guide: Travelling with an IMD

18th February 2025

Sarah, our Communities Lead, sat down with Sophia, mum to two boys living with classical homocystinuria (HCU), to talk about travelling with an inherited metabolic disorder. In this conversation, Sophia shares her practical tips, honest insights and tried and tested tricks to help make travelling with a metabolic condition that little bit easier.

Click the button below watch the video:

NICE Committee Recommends Pegzilarginase for ARG1-D, Pending Final Approval

17th February 2025

Interested in a potential new treatment for ARG1-D?

Click the button below to read our article:

Monthly Medicines Roundup for January

1st February 2026

Interested in the reading our Monthly Medicines Roundups for January

Click the button below to find out more:

Monthly Medicines Roundup & 2026 Forecast

1st January 2026

Interested in the reading our Monthly Medicines Roundups for December and forecast for 2026?

Click the button below to find out more:

What does the Autumn Budget 2025 mean for people living with IMDs

18th December 2025

Seen the autumn budget and wondered what it means for you?

Click the button below to read our article:

The UK-US pharma trade deal and how it impacts people with IMDs

17th December 2025

We’ve published an article so you can better understand the UK-US pharmaceutical trade deal and what it means for IMDs:

Click the button below to find out more:

ABPI Spotlights Our “True Faces of Rare” Project in New Case Study

15th December 2025

ABPI have published a case study on our joint project with Chiesi UK and Ireland which promotes the use of authentic imagery of people living with rare diseases in health communications

Click the button below to find out more:

The Inequity of Rare Disease

11th December 2025

“Inequity isn’t just a moral failure – it’s a scientific one.” Discover why our system still leaves rare communities behind, and what needs to change.

Click the button below to find out more:

Monthly Medicines Roundup for November

1st December 2025

Interested in the reading our Monthly Medicines Roundups for November?

Click the button below to find out more:

SMC Approves Procysbi for NHS Scotland Use

10th November 2025

SMC has accepted mercaptamine (Procysbi) for use within NHSScotland.

Click the button below to read our statement:

Research Release: Lived Experience of LC-FAODs

6th November 2025

Interested in the findings of our latest research “The Lived Experience of Long Chain Fatty Acid Oxidation Disorders”.

Click the button below to find out more:

Monthly Medicines Roundup for October

1st November 2025

Interested in the reading our Monthly Medicines Roundups for October?

Click the button below to find out more:

MSUK Statement on MTHFR enquiries

24th October 2025

Read our statement regarding MTHFR enquiries:

Click the button below to find out more:

Read the Think Ammonia: Year One Report

Our Think Ammonia year one report is now live!

This campaign was inspired by your stories and honours the memory of 16-year-old Rohan Godhania and others who have experienced disability or death because of high ammonia. This report shares the progress made possible through collaboration and sets out the next steps to improve outcomes globally.

Read the report by clicking the button, below 👇

Research Release: The Lived Experience of Thymidine Kinase 2 deficiency

13th October 2025

Interested in the findings of our latest research “The Lived Experience of Thymidine Kinase 2 Deficiency”.

Click the button below to find out more:

Monthly Medicines Roundup for September

1st October 2025

Interested in the reading our Monthly Medicines Roundups for September?

Click the button below to find out more:

Update on the assessment of Triheptanoin for LC-FAODs

11th September 2025

Read our update on the assessment of Triheptanoin for LC-FAODs.

Click the button below to find out more:

What does the 10-year plan mean for IMDs?

9th September 2025

Discover what the NHS 10-year plan means for people with IMDs in our latest article.

Click the button below to find out more:

Update on Pegzilarginase for ARG-1D

4th September 2025

NICE will review pegzilarginase for ARG1D again at a committee meeting on 18 September 2025, following new evidence. A final decision is expected by 12 November 2025.

Click the button below to find out more:

Monthly Medicines Roundup for August

1st September 2025

Interested in the reading our Monthly Medicines Roundups for August?

Click the button below to find out more:

Breakthrough treatment for IMDs

22nd August 2025

Mitochrondrial donation has been used to treat mitochondrial disorders.

Click the button below to find out more:

Personalised gene editing treats an IMD

14th August 2025

CPS1 deficiency has been treated with personalised gene therapy:

Click the button below to find out more:

Monthly Medicines Roundup for July

1st August 2025

Interested in the reading our Monthly Medicines Roundups for July?

Click the button below to find out more:

Monthly Medicines Roundup for June

1st July 2025

Interested in the reading our Monthly Medicines Roundups for June?

Click the button below to find out more:

Update on the assessment of Pegzilarginase for treating Arginase-1 Deficiency

26th June 2025

NICE has shared an update on pegzilarginase for ARG1D. It is not currently recommended, though the decision isn’t final. A three-week consultation is open to share more evidence.

Click the button below to find out more:

Update on the assessment of Fosdenopterin for MOCD Type A

25th June 2025

We’re saddened to share that the application to provide fosdenopterin on the NHS in England has been withdrawn, and the assessment has ended. We understand this may be distressing, and we’re here for you.

Click the button below to find out more:

Government Green Paper and IMDs

11th June 2025

Read about the government’s green paper and have your say.

Click the button below to find out more:

Monthly Medicines Roundup for May

30th May 2025

Interested in the reading our Monthly Medicines Roundups for May?

Click the button below to find out more:

The Multi-Dale Challenge

30th May 2025

The Multi-Dale challenge fundraiser organised by Mike and Fiona Rivett.

Click the button below to find out more:

The Lived Experience of Arginase-1 Deficiency

29th May 2025

Read the results of our research, “The Lived Experience of Arg 1-D.” 

Click the button below to find out more:

Tayyibah’s story: Argininosuccinic aciduria (ASA)

21st May 2025

Read Tayyibah’s story about life with Argininosuccinic aciduria (ASA).

Click the button below to find out more:

Your Monthly Medicines Roundup for April

1st May 2025

Interested in the reading our Monthly Medicines Roundups for April?

Click the button below to find out more:

Update on the assessment of Triheptanoin for LC-FAODs

29th April 2025

Read our update on the assessment of Triheptanoin for LC-FAODs.

Click the button below to find out more:

Your Monthly Medicines Roundup for March

31st March 2025

Interested in the reading our Monthly Medicines Roundups for March?

Click the button below to find out more:

MSUK statement on FRAT testing for Cerebral Folate Deficiency

7th April 2025

Read our statement on FRAT testing for Cerebral Folate Deficiency.

Click the button below to find out more:

MSUK's Living Well Statement on Proposed Benefit Changes

March 2025

What do the proposed changes to disability benefits mean to our communities?

Click the button below to read our full statement:

Community Shoutout: Julia Clamp

2025

Read how Julia is raising awareness about high ammonia in memory of her son.

Click the button below to find out more:

Your Monthly Medicines Roundup for February

28th February 2025

Interested in the reading our Monthly Medicines Roundups for February?

Click the button below to find out more:

MSUK's response to NICE HST consultation

4th February 2025

NICE’s HSTs aim to ensure fair evaluation for rare disease drugs despite limited evidence. Read our response to the HST consultation.

Click the button below to find out more:

Your Monthly Medicines Roundup for January

31st January 2025

Interested in the reading our Monthly Medicines Roundups for January?

Click the button below to find out more:

Research Release: Lived experience of MOCD A

24th January 2025

Interested in the findings of our latest research “The Lived Experience of Molybdenum Cofactor Deficiency Type A”. 

Click the button below to find out more:

Update on fosdenopterin for treating MOCD A

13th January 2025

Interested in our medicines update on fosdenopterin for treating MOCD A?

Click the button below to find out more:

Your Monthly Medicines Roundup for December

6th January 2025

Interested in the reading our Monthly Medicines Roundups for December?

Click the button below to find out more:

Newborn Screening Update: Tyrosinaemia Type One

19th December 2024

Interested in hearing the latest on newborn screening for tyrosinaemia type one?

Click the button below to read more:

Your Monthly Medicines Roundup for November

2nd December 2024

Interested in the reading our Monthly Medicines Roundups for November?

Click the button below to find out more:

What does the Autumn Budget mean for IMDs?

5th November 2024

Interested in learning more about the budget?

Click the button below to find out more:

Research: Cysteamine and Cystinosis

4th November 2024

Interested in the results of our research?

Click the button below to find out more:

Your Monthly Medicines Roundup for October

1st November 2024

Interested in the reading our Monthly Medicines Roundups for October?

Click the button below to find out more:

Update: Fosdenopterin for the treatment of MOCD Type A

22nd October 2024

Read our latest update about the use of Fosdenopterin for the treatment of MOCD Type A on our medcicines consultatations page.

Click the button below to find out more:

First newborns enrolled in a study aiming to diagnose rare diseases early

3rd October 2024

Read our update on the Generation Study, a research project aiming to diagnose rare diseases early using Whole Genome Sequencing.

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for September 2024

1st October 2024

Interested in the reading our Monthly Medicines Roundups for September?

Click the button below to find out more:

The "Living Well" Movement

24th September 2024

Learn about our “Living Well” movement and find out how you can get involved!

Click the button below to find out more:

The Adult Rare Bone Disease Network

21st September 2024

Learn about the Adult Rare Bone Disease Network and refer cases for review:

Click the button below to find out more:

"Treatment for ARG1d: Call to Action" next to a graphic of a medicine bottle.

Update on fosdenopterin for MOCD Type A

19th September 2024

Learn about the current NICE position on this treatment and get involved in the process.

Click the button below to find out more:

"Treatment for ARG1d: Call to Action" next to a graphic of a medicine bottle.

NICE draft guidance on the treatment of ARG1d

6th September 2024

Interested in the draft guidance on pegzilarginase for the treatment of ARG1d?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for August 2024

1st September 2024

Interested in the reading our Monthly Medicines Roundups for August?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

The UK NSC Explained

15th August 2024

Interested in learning how conditions are added to the newborn screening panel?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Falak's Story: MMA Mut 0

12th August 2024

Hear from Falak about her experience Mut 0, the most severe form of methylmalonic acidemia

Click the button below to read the article:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Register for our conference

August 2024

Interested in attending our annual community conference at The Studio, Birmingham?

Click the button below to register for the conference:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Alex & Mark Fenwick: Climbing for MSUK

6th August 2024

Hear from Alex and Mark about their fundraiser for MSUK!

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Pavel: My Time at the EURORDIS Open Academy

2nd August 2024

Interested in the reading Pavel’s blog about the Open Academy?

Click the button below to read the article:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for July 2024

1st August 2024

Interested in the reading our Monthly Medicines Roundups for July?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Metabolic Matters Your Journey: Discussing Death

30th July 2024

Read our latest edition of the Metabolic Matters magazine.

Click the button below to read this edition:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Check out the Research Ready Hub & A2M E-modules

30th July 2024

Visit the Research Ready Hub and E-Modules from MSUK

Click the button below to access the hub:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for June 2024

1st July 2024

Interested in the reading our Monthly Medicines Roundups for June?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for May 2024

30th May 2024

Interested in the reading our Monthly Medicines Roundups so far?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Rhiannon: Volunteering at MSUK

24th May 2024

Ever wondered what volunteering for MSUK is like?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for April 2024

1st May 2024

Interested in the latest medicines developments for April?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for March 2024

1st April 2024

Interested in the latest medicines developments for March?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Great news for Tyrosinaemia Type One

15th March 2024

English government endorses newborn screening for HT1

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for February 2024

1st March 2024

Interested in the latest medicines developments for February?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Student Voice Prize Essay on Rare Disease

6th February 2024

Amy’s essay discusses issues faced by people living with rare diseases.

Click the button below to read Amy’s Essay:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Your Monthly Medicines Roundup for January 2024

1st February 2024

Interested in the latest medicines developments for January?

Click the button below to find out more:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Our "Think Ammonia!" campaign

3rd January 2024

Interested in learning about our “Think Ammonia!” campaign?

Click the button below to visit the  campaign page:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Managing leukodystrophy in employment

11th December 2023

Interested in Alex TLC’s resource for employment?

Click the button below to visit the Alex TLC information page:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

We're supporting the Adult Rare Disease Bone Network

8th December 2023

Want to learn more about the adult rare bone network?

Click the button below to read more about the network:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Excipients in pharmaceutical products

7th December 2023

Learn more about excipients in pharmaceutical products.

Click the button below to read the full statement:

The background is a pale blue overlayed with a white net. </p>
<p>In the centre of the image is the Thoughts into Action cover which says "Thoughts into Action" and has a caption reading "What is quality of life as defined by people living with inherited metabolic disorders?". </p>
<p>The cover also has pale pink and white wavy graphics and an image of three people in the bottom left corner, a man with tattoos, a lady in a wheelchair and a man in a purple t-shirt.

The Autumn Statement mean for people living with Inherited Metabolic Disorders?

29th November 2023

Interested in the government’s Autumn Statement but can’t make heads or tails of it? We’ve taken a look and have broken down the key points for people living with inherited metabolic disorders.

 

Interested in reading more? Click the button below:

The background is a pale blue overlayed with a white net. </p>
<p>In the centre of the image is the Thoughts into Action cover which says "Thoughts into Action" and has a caption reading "What is quality of life as defined by people living with inherited metabolic disorders?". </p>
<p>The cover also has pale pink and white wavy graphics and an image of three people in the bottom left corner, a man with tattoos, a lady in a wheelchair and a man in a purple t-shirt.

Read our Thoughts into Action report

25th September 2023

We’ve released our Thoughts into Action report which was informed by research into identifying what good quality of life is for our communities, using a methodology that allowed our communities to speak, on their own terms, and for their stories to be meaningfully used to affect direct change.

 

Interested in reading our report? Click the button below:

The importance of hyperammonaemia awareness

14th September 2023

We’re supporting measures to prevent hyperammonaemia following the death of Rohan Godhania, who died as a result of consuming a protein shake whilst living with undiagnosed ornithine transcarbamylase (OTC) deficiency.

Click the button to read the more:

Meet Megan: Spotlight on the University of Essex

1st September 2023

Megan Fryer-Kelsey, a previous placement student has been featured in a national campaign highlighting the value of university!

Click the button to read the more:

We're calling for action to prevent hyperammonaemia

30th August 2023

We were contacted by Food Navigator Europe to comment on how to prevent deaths due to hyperammonaemia.

Click the button to read the article:

Genetic Testing and Insurance

23rd August 2023

The Association of British Insurers (ABI) have recently updated their consumer guide on the code for genetic testing and insurance.

Click the button to see what this means and how the code can help you:

Blue sky background overlayed with a graphic of a man with a beard looking at a large strand of double helix DNA with a maroon colour.

Mental Health Matters: The Unseen Issue in Metabolics

26th July 2023

Mental health often isn’t prioritised for people living with IMDs, this needs to change.

Click the button below for our statement on mental health:

Blue sky background overlayed with the Thoughts Into Action project logo which is the outline of a persons head with a lightbulb at the centre.

We're working against ticket office closures.

25th July 2023

MSUK have signed a joint letter from Transport for All condemning the closure of train ticket offices.

Click the button below to learn more:

Blue sky background overlayed with the Thoughts Into Action project logo which is the outline of a persons head with a lightbulb at the centre.

We've launched our Thoughts Into Action project.

5th April 2023

We’re aiming to find out what Quality of Life is as defined by our communities.

Click the button below to learn more and to get involved.

We've released Issue 11 of Metabolic Matters!

3rd April 2023

Read our first edition of the year which delves into the London Marathon, HPP and policy.

Click the button below to learn more:

Why make accessing essential benefits a burden?

29th March 2023

The Health and Disability White Paper was supposed to fix the “broken” benefits system.

Click the button below to learn more:

New treatment for rare inherited disorder

23rd March 2023

NICE final draft guidance recommends new treatment for primary hyperoxaluria type 1 (PH1)

Click the button below to learn more:

The Spring Budget and people living with IMDs

15th March 2023

Interested in the support offered as part of the UK Government’s Spring Budget?

Click the button below to learn more:

NBS Collaborative: New hope for newborn screening

1st March 2023

We’re working towards a future in which more rare conditions are screened for in newborn screening

Click the button below to learn more:

The Cost of Living with an Inherited Metabolic Disorder

28th February 2023

Read how the current economic climate is affecting our communities in our new report.

Click the button below to learn more:

Tyrosinaemia Type One Recomended for Screening

2nd February 2023

The UK NSC has recommended that TYR1 should be added to the UK newborn screening panel

Click the button below to learn more:

A momentous milestone for people living with HPP

1st February 2023

Final Draft Guidance Recommends Asfotase alfa (Strensiq) for use for the treatment of Paediatric-onset HPP

Click the button below to learn more:

The England Rare Disease Action Plan

19th January 2023

Back in 2022 we launched our England Rare Disease Explainer series highlighting the priorities and actions of this plan, want to revisit them?

Click the button below to learn more:

Social Tariff for Energy Bills

17th January 2023

MSUK, along with 95 charities and patient organisations are calling upon the Chancellor of the Exchequer to introduce discounted energy bills for low-income households.

Click the button below to read more:

The Scotland Rare Disease Action Plan

12th January 2023

Interested in learning about The Scotland Rare Disease Action Plan that was launched on the 19th December 2022?

Click the button below to learn more:

The true cost of living..

12th January 2023

We recently shared our Cost-of-Living survey which aimed to understand the effects of the current economic climate on our communities. 

Click the button below to read what we found about specialised diets:

The Autumn Statement and You

22nd November 2022

100% of the IMD community members we asked have been affected by the cost-of-living crisis and the cost of energy was the biggest concern.

Click the button below to read The Autumn Statement and You:

Skip to content